Company: NDRA
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001654954-25-011931
Chunk: 30

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 30
---
 release of any and all claims he may have against the Company, its affiliates, and their respective representatives and other related parties. However, the coverage ended in March 2025 when Mr. Michelon’s coverage pursuant to new employment began. The healthcare coverage totaled $11,937.

Previously, the Company was party to an employment agreement with Francois Michelon, effective May 12, 2017 and amended on December 27, 2019. Pursuant to the employment agreement, , Mr. Michelon received an annual base salary of $295,580 during the time of his employment in 2024. Mr. Michelon was also eligible for an annual cash bonus based upon the achievement of performance-based objectives established by the Board of Directors.

| 23 |

Irina Pestrikova. On August 8, 2024, Ms. Pestrikova stepped down as Senior Director, Finance, but continued to provide services from time to time for the Company to assist with the transition. Prior to that, Ms. Pestrikova was employed by the Company pursuant to an Offer Letter by and between the Company and Ms. Pestrikova, dated as of June 9, 2021. Ms. Pestrikova’s annual salary was $185,000. Per the terms of her offer letter, Ms. Pestrikova was eligible to receive employee benefits plans including medical, dental, vision, and 401(k) plans.

Outstanding Equity Awards at 2024 Fiscal Year End

The following table provides information regarding equity awards held by the named executive officers as of December 31, 2024.

|                                                          |     | Option Awards                                                       |    |     |                                                                       |    |    |     |                           |          |     |                       |   |
|                                                          |     | Number of Securities Underlying Unexercised Options (#) Exercisable |    |     | Number of Securities Underlying Unexercised Options (#) Unexercisable |    |    |     | Option Exercise Price ($) |          |     | Option ExpirationDate |   |
| Alexander Tokman                                         |     |                                                                     |  - |     |                                                                       |    |    |     |                           |  175,000 |     | 5/12/25               |   |
| Chief Executive Officer                                  |     |                                                                     |  - |     |                                                                       |    |    |     |                           |  173,250 |     | 1/2/26                |   |
|                                                          |